Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review-Reference-Cited by-同舟云学术

Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review

Published:2020-06 Issue:6 Volume:189 Page:1057-1058
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ahmed Maria Zahid¹^ORCID,Khakwani Muhammad¹^ORCID,Venkatadasari Indrani¹,Horgan Claire¹,Giles Hannah¹,Jobanputra Shailesh¹,Lokare Anand¹,Ewing Joanne¹,Paneesha Shankara¹,Murthy Vidhya¹

Affiliation:

1. Department of Haematology University Hospitals Birmingham NHS Foundation Trust Birmingham UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16769

Reference9 articles.

1. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

2. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes

3. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study

4. Hematologic parameters in patients with COVID‐19 infection

5. Mechanism of thrombocytopenia in COVID‐19 patients;Xu P;Ann Hematol,2020

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent, Poorly Responsive Immune Thrombocytopenia Secondary to Asymptomatic COVID-19 Infection in a Child;Case Reports in Infectious Diseases;2023-12-15

2. Population-Based Model of the Fraction of Incidental COVID-19 Hospitalizations during the Omicron BA.1 Wave in the United States;COVID;2023-05-08

3. Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland;Oncology Research and Treatment;2023

4. Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie;Oncology Research and Treatment;2022-12-26

5. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection;International Immunopharmacology;2022-11